Author:
Zhou You,Fu Chao,Kong Yidi,Pan Desi,Wang Yanan,Huang Shengjian,Li Zhibin,Ning Zhiqiang,Lu Xianping,Shan Song,Xin Lijun
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Reference33 articles.
1. Hepatocellular carcinoma: a global view.;Yang;Nat Rev Gastroenterol Hepatol,2010
2. Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy.;Hsu;Hepatol Int,2013
3. Sorafenib in advanced hepatocellular carcinoma.;Llovet;N Engl J Med,2008
4. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.;Bruix;Lancet,2017
5. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.;El-Khoueiry;Lancet,2017
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献